In terms of the global market, India currently holds a modest 1-2% share, but it has been growing at approximately
10% per year. India gained its foothold on the global scene with its innovatively-engineered generic drugs and active pharmaceutical ingredients (API), and it is now seeking to become a major player in outsourced clinical research as well as contract manufacturing and research. There are 74 U.S. FDA-approved manufacturing facilities in India, more than in any other country outside the U.S, and in 2005, almost 20% of all Abbreviated New Drug Applications (ANDA) to the FDA are expected to be filed by Indian companies.

Hyderabad being hub of bulk drug industry and clinical research there are plenty of opportunities in R&D sector. We at Vishnu Institute of Pharmaceutical Education and Research strive to provide practical skills for our students to cater the needs in Pharma industry. We are trying to have collaborations with industries making sure the students get bright exposure towards latest developments in pharma R&D.

©2011. Vishnu Institute of Pharmaceutical Education & Research.